19338005: 2 (qualifier value)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

32597014 Two en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442102012 2 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3442103019 2 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

33051000077117 deux fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
deux	Is a	General adjectival modifier	false	Inferred relationship	Some
deux	Is a	nombre	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely fluconazole 2 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely morphine sulfate 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hypromellose 2 milligram/1 milliliter conventional release eye solution (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Paracetamol 650 mg and pentazocine 25 mg oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Clemastine fumarate 670 microgram and phenylpropanolamine 25 mg oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely budesonide 160 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely budesonide 80 microgram and formoterol 4.5 microgram/1 actuation conventional release powder for inhalation (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Chlorpromazine hydrochloride 2 mg/mL oral solution	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and prilocaine hydrochloride 40 mg/mL solution for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely glucose 100 milligram/1 milliliter and sodium chloride 1.8 milligram/1 milliliter conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely hydrocortisone 2 milligram/1 milliliter conventional release oral suspension (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely cocaine (as cocaine hydrochloride) 50 milligram/1 milliliter and epinephrine 200 microgram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dextromethorphan hydrobromide 60 mg and guaifenesin 1.2 g prolonged-release oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Benserazide 12.5 mg and levodopa 50 mg oral tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely dextromethorphan hydrobromide 30 milligram and guaifenesin 600 milligram/1 each prolonged-release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely salbutamol (as salbutamol sulfate) 2 milligram/1 milliliter conventional release solution for inhalation (clinical drug)	Has concentration strength numerator value	False	deux	Inferred relationship	Some	1
Neomycin and prednisolone only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Betamethasone and neomycin only product in otic dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Betamethasone and neomycin only product in nasal dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrocortisone and neomycin only product in otic dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only hydrocortisone and neomycin in ocular dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only neomycin and prednisolone in otic dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Acetic acid and oxyquinoline only product in vaginal dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Acetic acid and oxyquinoline only product	Count of base of active ingredient	False	deux	Inferred relationship	Some
Menthol 30 microgram/mg and methyl salicylate 100 microgram/mg cutaneous patch	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cefoperazone (as cefoperazone sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cilastatin (as cilastatin sodium) 500 milligram and imipenem anhydrous (as imipenem) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Ceftizoxime (as ceftizoxime sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Piperacillin anhydrous (as piperacillin sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely chlorhexidine gluconate 500 microgram/1 milliliter and tetracaine 150 microgram/1 milliliter conventional release oral spray (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cannabinol 25 milligram/1 milliliter and tetrahydrocannabinol 27 milligram/1 milliliter conventional release oral spray (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely cefamandole (as cefamandole nafate) 2 gram/1 vial powder for conventional release solution for injection (clinical drug)	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Carbidopa anhydrous (as carbidopa) 25 mg and levodopa 250 mg orodispersible tablet	Count of base of active ingredient	False	deux	Inferred relationship	Some
Pituitary follicle stimulating hormone 150 unit and pituitary luteinizing hormone 150 unit powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Lidocaine 25 mg/mL and prilocaine 25 mg/mL dental gel	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Coagulation factor VIII 1000 unit and von Willebrand factor 2500 unit powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cilastatin (as cilastatin sodium) 250 mg and imipenem anhydrous (as imipenem) 250 mg powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Cefmetazole (as cefmetazole sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Coagulation factor VIII 500 unit and von Willebrand factor 1250 unit powder for solution for injection vial	Count of base of active ingredient	False	deux	Inferred relationship	Some
Mezlocillin (as mezlocillin sodium) 2 g powder for solution for injection vial	Has presentation strength numerator value	False	deux	Inferred relationship	Some	1
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely coal tar 25 milligram/1 milliliter and lecithin 3 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing precisely salicylic acid 30 milligram/1 milliliter and sulfur 50 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution	Count of base of active ingredient	False	deux	Inferred relationship	Some
Mequinol and tretinoin only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only aspirin and glycine in oromucosal dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Loteprednol and tobramycin only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Calcium phosphate and carmellose only product in parenteral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Ciprofloxacin and dexamethasone only product in otic dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only dextromethorphan and guaifenesin in oral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Dextromethorphan and promethazine only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Fenoterol and ipratropium only product in pulmonary dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only fluorescein stain and proxymetacaine in ocular dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Frangula and Sterculia gum only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Fluorometholone and tobramycin only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only cinchocaine and prednisolone in rectal dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Diiodohydroxyquinoline and hydrocortisone only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only ampicillin and sulbactam in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Salicylic acid and zinc oxide only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only diphenhydramine and zinc acetate in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Betamethasone and calcipotriol only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only mucin and xylitol in oromucosal dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Naphazoline and pheniramine only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only clindamycin and tretinoin in cutaneous dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Acetic acid and hydrocortisone only product in otic dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Brimonidine and timolol only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Coal tar and lecithin only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only sodium benzoate and sodium phenylacetate in parenteral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only bromazine and codeine in oral dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Nicotinic acid and simvastatin only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Product containing only cocaine and epinephrine in ocular dose form (medicinal product form)	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydrocortisone and pramocaine only product in cutaneous dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Hydroxyamfetamine and tropicamide only product in ocular dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Adrenaline and etidocaine only product in parenteral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Codeine and kaolin only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Adrenaline and mepivacaine only product in parenteral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Adrenaline and bupivacaine only product in parenteral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Ipratropium and salbutamol only product in pulmonary dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some
Esterified estrogen and methyltestosterone only product in oral dose form	Count of base of active ingredient	False	deux	Inferred relationship	Some

Start Previous Page 22 of 24 Next End

Reference Sets

Concept inactivation indicator reference set

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
32597014	Two	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442102012	2 (qualifier value)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3442103019	2	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
33051000077117	deux	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module